List of Excipients in API REPAGLINIDE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing REPAGLINIDE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Padagis US LLC | repaglinide | 0574-0240 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE |
| Padagis US LLC | repaglinide | 0574-0240 | CELLULOSE, MICROCRYSTALLINE |
| Padagis US LLC | repaglinide | 0574-0240 | GLYCERIN |
| Padagis US LLC | repaglinide | 0574-0240 | MAGNESIUM STEARATE |
| Padagis US LLC | repaglinide | 0574-0240 | MEGLUMINE |
| Padagis US LLC | repaglinide | 0574-0240 | POLACRILIN POTASSIUM |
| Padagis US LLC | repaglinide | 0574-0240 | POLOXAMER 407 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for REPAGLINIDE
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
REPAGLINIDE drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
REPAGLINIDE drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | repaglinide | 33342-248 |
| Amneal Pharmaceuticals LLC | repaglinide | 60846-882 |
| Chartwell RX LLC | repaglinide | 62135-946 |
| NorthStar RxLLC | repaglinide | 72603-810 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYANISOLE
REPAGLINIDE drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | repaglinide | 33342-248 |
| Bryant Ranch Prepack | repaglinide | 71335-2554 |
| Bryant Ranch Prepack | repaglinide | 71335-2598 |
| NorthStar RxLLC | repaglinide | 72603-810 |
| >Company | >Ingredient | >NDC |
REPAGLINIDE drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
REPAGLINIDE drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | repaglinide | 33342-248 |
| Amneal Pharmaceuticals LLC | repaglinide | 60846-882 |
| NorthStar RxLLC | repaglinide | 72603-810 |
| >Company | >Ingredient | >NDC |
REPAGLINIDE drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CELLULOSE, MICROCRYSTALLINE
REPAGLINIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
REPAGLINIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
REPAGLINIDE drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | repaglinide | 57664-745 |
| Amneal Pharmaceuticals LLC | repaglinide | 60846-882 |
| >Company | >Ingredient | >NDC |
REPAGLINIDE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
REPAGLINIDE drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | repaglinide | 62135-946 |
| >Company | >Ingredient | >NDC |
REPAGLINIDE drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FERRIC OXIDE RED
REPAGLINIDE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | repaglinide | 63629-8363 |
| Bryant Ranch Prepack | repaglinide | 63629-8449 |
| Bryant Ranch Prepack | repaglinide | 63629-9194 |
| Bryant Ranch Prepack | repaglinide | 71335-2598 |
| Bryant Ranch Prepack | repaglinide | 72162-1114 |
| >Company | >Ingredient | >NDC |
REPAGLINIDE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
REPAGLINIDE drug variants containing FERRIC OXIDE YELLOW
REPAGLINIDE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: GLYCERIN
REPAGLINIDE drug variants containing GLYCERIN
REPAGLINIDE drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | repaglinide | 51991-853 |
| Sun Pharmaceutical Industries Inc | repaglinide | 57664-745 |
| Golden State Medical Supply Inc | repaglinide | 60429-484 |
| Amneal Pharmaceuticals LLC | repaglinide | 60846-882 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
REPAGLINIDE drug variants containing MAGNESIUM STEARATE
REPAGLINIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEGLUMINE
REPAGLINIDE drug variants containing MEGLUMINE
REPAGLINIDE drug variants not containing MEGLUMINE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | repaglinide | 51991-853 |
| Golden State Medical Supply Inc | repaglinide | 60429-484 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLACRILIN POTASSIUM
REPAGLINIDE drug variants containing POLACRILIN POTASSIUM
REPAGLINIDE drug variants not containing POLACRILIN POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | repaglinide | 57664-745 |
| Amneal Pharmaceuticals LLC | repaglinide | 60846-882 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 181
REPAGLINIDE drug variants containing POLOXAMER 181
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | repaglinide | 57664-745 |
| Amneal Pharmaceuticals LLC | repaglinide | 60846-882 |
| >Company | >Ingredient | >NDC |
REPAGLINIDE drug variants not containing POLOXAMER 181
Excipient focus: POLOXAMER 188
REPAGLINIDE drug variants containing POLOXAMER 188
REPAGLINIDE drug variants not containing POLOXAMER 188
Excipient focus: POLOXAMER 407
REPAGLINIDE drug variants containing POLOXAMER 407
REPAGLINIDE drug variants not containing POLOXAMER 407
Excipient focus: POVIDONE
REPAGLINIDE drug variants containing POVIDONE
REPAGLINIDE drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | repaglinide | 51991-853 |
| Golden State Medical Supply Inc | repaglinide | 60429-484 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
REPAGLINIDE drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | repaglinide | 51991-853 |
| Golden State Medical Supply Inc | repaglinide | 60429-484 |
| >Company | >Ingredient | >NDC |
REPAGLINIDE drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
REPAGLINIDE drug variants containing SILICON DIOXIDE
REPAGLINIDE drug variants not containing SILICON DIOXIDE
Excipient focus: STARCH, CORN
REPAGLINIDE drug variants containing STARCH, CORN
REPAGLINIDE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | repaglinide | 51991-853 |
| Golden State Medical Supply Inc | repaglinide | 60429-484 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
REPAGLINIDE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | repaglinide | 62135-946 |
| >Company | >Ingredient | >NDC |
REPAGLINIDE drug variants not containing TALC
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links